Named ‘Teawell 95’, the extract has a 95% concentration of the catechin epigallocatechin-3-gallate (EGCG): among the highest purities available on the market today.
EGCG is considered the most potent of the four green tea catechins and has been shown to provide a range of health benefits.
Studies have shown that it can help with weight management, maintaining healthy blood glucose control and cardiovascular health. It is also a strong antioxidant.
Tate & Lyle plan to launch Teawell 95 as a part of its ENRICH offering at the Vitafoods fair.
Tate & Lyle will be showcasing a number of innovative prototypes including a juice drink, an iced tea, an isotonic drink, a white yogurt and a fruit yogurt, which build on the synergy between Teawell 95 and key Tate & Lyle ingredients; Splenda Sucralose, Polydextrose and Fructose.
Commenting on the announcement, James Blunt, vice president sales & marketing, EMEA for Tate & Lyle said: “In recent years we have seen a huge surge of interest in functional food and drinks, as consumers become increasingly aware of the importance of eating and drinking well.
“We have also observed that green tea is becoming more and more popular in the west. This agreement will help us to respond to both of these trends, allowing us to develop a range of healthy products that taste great.”
Christine Renken, A Holliday & Company Inc director of sales, said: “Teawell 95 is really the powerhouse of tea. Because EGCG is the most potent of the four catechins found in tea, it not only provides wide ranging health benefits, but offers a huge range of possible applications.
“Building on this high quality product and Tate & Lyle’s applications expertise, we are confident we will be able to expand our market and position Teawell in new products which we think will be extremely popular with today’s consumers.”
Source: Tate & Lyle
© FoodBev Media Ltd 2024